Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- COST +2.6% (also declares special dividend of $15/sh), X +0.6%
Other news:
- VRCA +12% (Development and commercialization partner Torii Pharmaceutical announces positive top-line results from a confirmatory phase 3 trial of to-208 for the treatment of molluscum contagiosum in Japan)
- ACIU +10.5% (announces that its development partner has programmed the launch of a Phase 2b clinical study to evaluate ACI-35.030 in patients with preclinical Alzheimer's disease those individuals not yet showing symptoms)
- TIGO +6.8% (raised target of cumulative equity free cash flow and launches share repurchase program)
- ENSG +5% (raises quarterly dividend to $0.06 per share from $0.0575 per share)
- ARIS +4.1% (selected by DoE to receive research grant)
- CHWY +3.9% (Director bought 15353 shares)
- ELAN +2.5% (activist investor Ancora has built a position; pushing for changes; according to Bloomberg Law)
- GE +2% (selected by NASA to work with its Hybrid Thermally Efficient Core project; upgraded to Overweight from Equal Weight at Wells Fargo)
- LNC +2% (to sell its wealth mgmt unit to Osaic for $700 mln)
- AMLI +1.7% (files updated mineral resource technical report on Falchani; measured and indicated resource increases 476% from previous 2019 mineral resource estimate)
- FIBK +1.4% (entered into repurchase agreement with Scott Family FIBK Shareholder Group)
- CIB +1.4% (announces that the Colombian stock exchange has authorized a liquidity program in Colombia for its ordinary and preferred shares with an initial term of one year from its execution)
- CEG +1.2% (approves $1 bln increase to repurchase program)
- CRBG +1.1% (announces $150 million share repurchase from AIG and Blackstone (BX))
- GNK +1.1% (provided an update to its estimated time charter equivalent rate for the fourth quarter)
- NUE +1% (increases dividend)
- C +1% (shutting down its Muni business according to Bloomberg)
- PFE +1% (increases dividend)
Analyst comments:
- CHD +1.2% (upgraded to Neutral from Underperform at BofA Securities)
- EFX +1.2% (upgraded to Overweight from Equal Weight at Wells Fargo)
- LHX +1.2% (upgraded to Buy from Hold at Deutsche Bank)
- MU +1.2% (upgraded to Buy from Neutral at BofA Securities)
- CL +1% (upgraded to Buy from Neutral at BofA Securities)
- CUBE +1% (upgraded to Outperform from Market Perform at BMO Capital Markets)